Sunday, April 25, 2010

IOM to Advise FDA on Post-Marketing Drug Safety Trials

The Institute of Medicine has been called upon to advise the FDA regarding post-marketing drug safety trials.  George Conk at Otherwise has the details.

--CJR

http://lawprofessors.typepad.com/tortsprof/2010/04/iom-to-advise-fda-on-postmarketing-drug-safety-trials.html

Current Affairs, Experts & Science | Permalink

TrackBack URL for this entry:

http://www.typepad.com/services/trackback/6a00d8341bfae553ef0133ecf1ead2970b

Listed below are links to weblogs that reference IOM to Advise FDA on Post-Marketing Drug Safety Trials:

Comments

Post a comment